1. Home
  2. UAA vs VERA Comparison

UAA vs VERA Comparison

Compare UAA & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

UAA

Under Armour Inc.

N/A

Current Price

$4.90

Market Cap

1.9B

ML Signal

N/A

Logo Vera Therapeutics Inc.

VERA

Vera Therapeutics Inc.

N/A

Current Price

$28.24

Market Cap

2.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
UAA
VERA
Founded
1996
2016
Country
United States
United States
Employees
N/A
362
Industry
Apparel
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
2.1B
IPO Year
2005
2021

Fundamental Metrics

Financial Performance
Metric
UAA
VERA
Price
$4.90
$28.24
Analyst Decision
Hold
Strong Buy
Analyst Count
26
14
Target Price
$6.24
★ $71.36
AVG Volume (30 Days)
★ 8.5M
1.5M
Earning Date
11-06-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ N/A
N/A
Revenue
★ $4,966,370,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$2.04
$725.75
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$4.13
$26.38
52 Week High
$8.15
$56.05

Technical Indicators

Market Signals
Indicator
UAA
VERA
Relative Strength Index (RSI) 46.64 40.99
Support Level $4.74 $26.92
Resistance Level $5.28 $36.95
Average True Range (ATR) 0.28 1.68
MACD -0.03 -0.07
Stochastic Oscillator 28.74 4.97

Price Performance

Historical Comparison
UAA
VERA

About UAA Under Armour Inc.

Under Armour develops, markets, and distributes athletic apparel, footwear, and accessories in North America, Asia-Pacific, Europe, and Latin America. Consumers of its performance-based clothing and shoes include professional and amateur athletes, sponsored college and professional teams, and people with active lifestyles. The company sells merchandise through wholesale partners, company-owned digital channels, and approximately 440 company-owned outlet and full-price stores. The Baltimore-based firm was founded in 1996 and is led by controlling shareholder Kevin Plank.

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

Share on Social Networks: